After failing to convince the government to look into possibly raising prices again, the Federation of Egyptian Industries (FEI) pharma division is taking its case to the House of Representatives, sources tell Al Borsa. The division plans to send a memo to the House beseeching them on the “tough time the pharma sector is going through” as a result of prices staying the same since January. Yet their pleas seem likely to fall on deaf ears, according to statements from House Health Committee member Samy Al Mashd. Driven mostly by foreign pharma companies, the FEI still plans to push the issue with the Ismail cabinet and are awaiting the return of Prime Minister Sherif Ismail from Germany to intensify lobbying efforts. After repeated snubs by the Health Ministry, the lobby group will apparently focus its efforts with the Trade and Industry Ministry and the Investment Ministry.
More from Enterprise
The National Bank of Egypt and Banque Misr just hiked rates on CDs — moves that could see the EGP gain against the USD
NBE and BM both hiked rates on CDs by 125…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Here’s why “temporary listings” are all the rage right now
The government plans to list Misr Travel and Egoth in…
Kiwe gets Central Bank green light to launch nationwide
The startup is backed by our friends at EFG Hermes,…